We are live on ! Find out more
CBPO

China Biologic Products Holdings, Inc.
CBPO

Delisted

CBPO was delisted on the 20th of April, 2021.

Back to rankings

18 hedge funds and large institutions have $273M invested in China Biologic Products Holdings, Inc. in 2013 Q2 according to their latest regulatory filings, with 18 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
18
Holders Change
+18
Holders Change %
–
% of All Funds
0.59%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
18
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
WP
1
Warburg Pincus
New York
$255M +$277M +10,989,200 New
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$4.06M +$4.46M +176,729 New
HSBC Holdings
3
HSBC Holdings
United Kingdom
$3.44M +$3.79M +150,000 New
BIT
4
BlackRock Institutional Trust
California
$2.56M +$2.79M +110,403 New
Invesco
5
Invesco
Georgia
$2.12M +$2.31M +91,413 New
Renaissance Technologies
6
Renaissance Technologies
New York
$1.97M +$2.14M +84,800 New
VAM
7
Visium Asset Management
New York
$919K +$1.01M +40,003 New
California Public Employees Retirement System
8
California Public Employees Retirement System
California
$714K +$785K +31,100 New
SIM
9
Spark Investment Management
New York
$625K +$689K +27,300 New
GCP
10
GSA Capital Partners
United Kingdom
$582K +$633K +25,093 New
PP
11
PDT Partners
New York
$563K +$619K +24,531 New
Morgan Stanley
12
Morgan Stanley
New York
$530K +$577K +22,848 New
BA
13
BlackRock Advisors
Delaware
$120K +$131K +5,172 New
RA
14
Royce & Associates
New York
$67K +$73.2K +2,900 New
BJ
15
BlackRock Japan
Japan
$58K +$62.9K +2,492 New
TRCT
16
Tower Research Capital (TRC)
New York
$42K +$45.3K +1,794 New
OA
17
OFI Advisors
Pennsylvania
$4K +$4.79K +190 New
Citigroup
18
Citigroup
New York
$2K +$1.82K +72 New

CBPO Hedge Fund Activity: Q2 2013 in Review

18 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in China Biologic Products Holdings, Inc. (CBPO) for Q2 2013, worth a combined $273M.

Buyers outnumbered sellers: 18 funds opened new CBPO positions and 0 closed out — a net gain of 18 holders — while 0 added to existing stakes and 0 trimmed.

  • 18 institutional investors held China Biologic Products Holdings, Inc. (CBPO) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $273M of China Biologic Products Holdings, Inc. stock for Q2 2013.
  • 18 funds opened new China Biologic Products Holdings, Inc. positions in Q2 2013 and 0 closed out, a net change of +18 holders.

Based on aggregated 13F filings for Q2 2013.